Kammerer, Martin
Hasler, Gregor
Hochstrasser, Barbara
Baumann, Axel
Sousek, Alexandra https://orcid.org/0009-0002-8226-540X
Funding for this research was provided by:
Lundbeck (Schweiz) AG
Article History
Received: 13 June 2025
Accepted: 10 February 2026
First Online: 15 March 2026
Declarations
:
: The study was funded by Lundbeck (Schweiz) AG and coordinated by the contract research organisation, ANFOMED GmbH. The sponsor distributed study documentation to clinicians participating in the study in accordance with the Pharma Code (Pharmakodex, 2015). The sponsor also reviewed the manuscript for scientific accuracy. All clinicians received an expense allowance for their involvement in the study, which was based on the time required to complete the relevant tasks (communicate information and complete study documentation) at each study visit.
: Martin Kammerer holds shares in Roche Pharma AG and Alpine Health AG, and reports speaker honoraria from Lundbeck and Servier. Gregor Hasler reports speaker/consultant fees from Janssen, Lundbeck, OM Pharma, Salon Pharma, Sanofi, Schwabe, Servier, Sunovion and Takeda. Barbara Hochstrasser is a member of the Advisory Board for vortioxetine of Lundbeck Pharma Switzerland, and a speaker at Lundbeck-sponsored symposia and teaching events for physicians. Axel Baumann is a member of the Swiss Advisory Board on Brintellix and Lundbeck and a speaker in Lundbeck-sponsored symposia. Alexandra Sousek is a full-time employee of Lundbeck (Schweiz) AG.
: On the 2 April 2017, the Ethics Committee of the Canton of Zurich confirmed that the study protocol did not require specific ethics approval because of its purely observational nature. The study complied with the Declaration of Helsinki.
: Written informed consent was obtained from all participants included in the study.
: Not applicable.
: The data that support the findings of this study are not openly available because of reasons of sensitivity and are available from the corresponding author upon reasonable request.
: Not applicable.
: Conceptualisation: MK. Methodology: MK. Formal analysis and investigation: MK, AB and AS. Writing (review and editing): MK, GH, BH, AB and AS. Supervision: AS. All authors have read and approved the published version of the manuscript and agreed to be accountable for all aspects of the work.